MedPath

Trial Using Integuseal as Microbial Sealant for Arterial Bypass Surgery on Lower Extremities

Not Applicable
Terminated
Conditions
Arterial Obstructive Diseases
Interventions
Procedure: Application of Integuseal sealant
Registration Number
NCT00940979
Lead Sponsor
Rijnstate Hospital
Brief Summary

The purpose of this study is to prove a reduction of postoperative wound infections after direct preoperative use of a microbial sealant in the form of Integuseal for vascular procedures on lower extremities.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
450
Inclusion Criteria
  • planned supragenual of infragenual peripheral arterial bypass procedures with autologue or prosthetic graft
Exclusion Criteria
  • secondary procedures and suprainguinal procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Use of IntegusealApplication of Integuseal sealantApplication of a layer of Integuseal (Cyanoacrylate) from a ready to use applicator preoperative before incision Polymerisation immobilise the bacteria that survived the conventional skin preparation This way there will be les contamination of the wound.
Primary Outcome Measures
NameTimeMethod
Postoperative wound infections
Secondary Outcome Measures
NameTimeMethod
Costs of the use of Integuseal
Complications during hospital stay

Trial Locations

Locations (3)

Ziekenhuis Nij Smellinghe

🇳🇱

Drachten, Netherlands

Ziekenhuis Rijnstate

🇳🇱

Arnhem, Netherlands

Ziekenhuis Slingland

🇳🇱

Doetinchem, Netherlands

© Copyright 2025. All Rights Reserved by MedPath